Active PriorityDeveloping
Johnson & Johnson Reaches $5.5 Billion Talc Settlement to End Decade-Long Litigation
worth trackingUpdated 2h ago
Key takeaway: Johnson & Johnson's $5.5 billion settlement for talc-related ovarian cancer claims resolves nearly all existing lawsuits, but requires 95% claimant acceptance and does not cover future litigation.
